194 related articles for article (PubMed ID: 11004278)
21. Orbital mass secondary to acute lymphoblastic leukaemia in a child: a rare presentation.
Chaudhry SR; Kreis AJ; Underhill HC; Madge SN
Orbit; 2014 Dec; 33(6):421-3. PubMed ID: 25207876
[TBL] [Abstract][Full Text] [Related]
22. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
[TBL] [Abstract][Full Text] [Related]
23. [Bilateral orbital myeloid sarcoma: the circumstance of the discovery of acute myeloid leukemia (a case report)].
Rambeloson R; Ranoasy NF; Randrianjafisamindrakotroka O; Andriamiadanalisoa AO; Raobela L
Pan Afr Med J; 2021; 39():145. PubMed ID: 34527161
[TBL] [Abstract][Full Text] [Related]
24. A rare case of GATA1 negative chemoresistant acute megakaryocytic leukemia in an 8-month-old infant with trisomy 21.
Stepensky P; Brooks R; Waldman E; Revel-Vilk S; Izraeli S; Resnick I; Weintraub M
Pediatr Blood Cancer; 2010 Jul; 54(7):1048-9. PubMed ID: 20108342
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia presenting as bilateral proptosis from diffuse extraocular muscle infiltration.
Chen E; Morrison DG; Donahue SP
Am J Ophthalmol; 2004 May; 137(5):948-50. PubMed ID: 15126169
[TBL] [Abstract][Full Text] [Related]
26. A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
Olatunji PO; Ojo OT; Bello FO; Bakare BY; Olatunji AO
Malawi Med J; 2018 Dec; 30(4):298-301. PubMed ID: 31798811
[TBL] [Abstract][Full Text] [Related]
27. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Holt SE; Brown EJ; Zipursky A
J Pediatr Hematol Oncol; 2002 Jan; 24(1):14-7. PubMed ID: 11902731
[TBL] [Abstract][Full Text] [Related]
28. Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome.
Ma SK; Lee AC; Wan TS; Lam CK; Chan LC
Leukemia; 1999 Mar; 13(3):491-2. PubMed ID: 10086746
[No Abstract] [Full Text] [Related]
29. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
Rodrigues EF; da Costa ES; Land MG; Diamond HR; Ornellas MH; Abdelhay E; Fernandez Tde S
Cancer Genet Cytogenet; 2009 Jan; 188(1):54-6. PubMed ID: 19061782
[No Abstract] [Full Text] [Related]
30. [Megakaryoblastic leukemia and transient abnormal myelopoiesis with Down's syndrome].
Suda J; Eguchi M
Rinsho Ketsueki; 1988 Aug; 29(8):1200-6. PubMed ID: 2974493
[No Abstract] [Full Text] [Related]
31. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
[TBL] [Abstract][Full Text] [Related]
32. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
33. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
Zipursky A; Brown E; Christensen H; Sutherland R; Doyle J
Semin Perinatol; 1997 Feb; 21(1):97-101. PubMed ID: 9190039
[TBL] [Abstract][Full Text] [Related]
34. Acute megakaryoblastic leukemia in Down syndrome, following thrombocytopenia with antiplatelet antibody.
Sumi S; Obayashi M; Murakami M; Ito J; Okada N; Shibata Y
Tohoku J Exp Med; 1990 May; 161(1):65-7. PubMed ID: 2144373
[TBL] [Abstract][Full Text] [Related]
35. [Proptosis as the first sign of recurrent scirrhous breast carcinoma].
Rodríguez-Marco NA; Domínguez-Polo AM; Cristóbal-Bescós JA; Sierra-Barreras J; Castillo-Laguarta J
Arch Soc Esp Oftalmol; 2005 Dec; 80(12):737-40. PubMed ID: 16372219
[TBL] [Abstract][Full Text] [Related]
36. GATA 1 mutations as clonal markers of minimal residual disease in acute megakaryoblastic leukemia of Down syndrome--a new tool with significant potential applications.
Hitzler J; Zipursky A
Leuk Res; 2005 Nov; 29(11):1239-40. PubMed ID: 15925405
[No Abstract] [Full Text] [Related]
37. More than meets the eye: a presentation of extramedullary infiltration (AML-M7).
Baldwin S; Mian A
Clin Pediatr (Phila); 2010 Oct; 49(10):986-8. PubMed ID: 20724319
[No Abstract] [Full Text] [Related]
38. Trisomy 3 as an acquired cytogenetic abnormality in primary acute megakaryoblastic leukemia.
Azad VF; Mehrvar A; Mehrvar N
J Cancer Res Ther; 2018 Sep; 14(Supplement):S800-S802. PubMed ID: 30249908
[TBL] [Abstract][Full Text] [Related]
39. [Acute megakaryoblastic leukemia. Relation to trisomy 21].
Levaltier X; Reman O; Boutard P; Mandard JC; Troussard X; Leporrier M
Arch Fr Pediatr; 1991 Oct; 48(8):563-6. PubMed ID: 1837448
[TBL] [Abstract][Full Text] [Related]
40. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.
Ribeiro RC; Oliveira MS; Fairclough D; Hurwitz C; Mirro J; Behm FG; Head D; Silva ML; Raimondi SC; Crist WM
Leuk Lymphoma; 1993 Jul; 10(4-5):299-306. PubMed ID: 8220128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
